Invacare (IVC) Stock Price, News & Analysis

Invacare Co. (NYSE:IVC) posted its earnings results on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to analysts' expectations of $222.27 million. Invacare had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 37.76%. During the same period in the previous year, the business posted ($0.10) EPS.

51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).